11-111853410-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024740.2(ALG9):c.865G>A(p.Val289Ile) variant causes a missense change. The variant allele was found at a frequency of 0.337 in 1,612,176 control chromosomes in the GnomAD database, including 95,607 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.29 ( 7454 hom., cov: 32)
Exomes 𝑓: 0.34 ( 88153 hom. )
Consequence
ALG9
NM_024740.2 missense
NM_024740.2 missense
Scores
1
4
13
Clinical Significance
Conservation
PhyloP100: 6.17
Genes affected
ALG9 (HGNC:15672): (ALG9 alpha-1,2-mannosyltransferase) This gene encodes an alpha-1,2-mannosyltransferase enzyme that functions in lipid-linked oligosaccharide assembly. Mutations in this gene result in congenital disorder of glycosylation type Il. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=9.7474855E-5).
BP6
Variant 11-111853410-C-T is Benign according to our data. Variant chr11-111853410-C-T is described in ClinVar as [Benign]. Clinvar id is 379945.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-111853410-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.569 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG9 | NM_024740.2 | c.865G>A | p.Val289Ile | missense_variant | 8/15 | ENST00000616540.5 | NP_079016.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG9 | ENST00000616540.5 | c.865G>A | p.Val289Ile | missense_variant | 8/15 | 1 | NM_024740.2 | ENSP00000482437.1 | ||
ENSG00000258529 | ENST00000622211.4 | c.1564G>A | p.Val522Ile | missense_variant | 12/19 | 2 | ENSP00000482396.1 |
Frequencies
GnomAD3 genomes AF: 0.294 AC: 44692AN: 151932Hom.: 7448 Cov.: 32
GnomAD3 genomes
AF:
AC:
44692
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.356 AC: 88629AN: 248626Hom.: 16822 AF XY: 0.356 AC XY: 48083AN XY: 134908
GnomAD3 exomes
AF:
AC:
88629
AN:
248626
Hom.:
AF XY:
AC XY:
48083
AN XY:
134908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.342 AC: 499046AN: 1460124Hom.: 88153 Cov.: 34 AF XY: 0.344 AC XY: 249609AN XY: 726432
GnomAD4 exome
AF:
AC:
499046
AN:
1460124
Hom.:
Cov.:
34
AF XY:
AC XY:
249609
AN XY:
726432
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.294 AC: 44714AN: 152052Hom.: 7454 Cov.: 32 AF XY: 0.302 AC XY: 22428AN XY: 74310
GnomAD4 genome
AF:
AC:
44714
AN:
152052
Hom.:
Cov.:
32
AF XY:
AC XY:
22428
AN XY:
74310
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1210
ALSPAC
AF:
AC:
1294
ESP6500AA
AF:
AC:
516
ESP6500EA
AF:
AC:
2653
ExAC
AF:
AC:
42265
Asia WGS
AF:
AC:
1495
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
ALG9 congenital disorder of glycosylation Benign:3
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 02, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Gillessen-Kaesbach-Nishimura syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;.;.
REVEL
Benign
Sift
Benign
.;T;T;.;.
Sift4G
Benign
T;T;T;T;T
Polyphen
D;.;.;D;.
Vest4
MPC
0.30
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at